Vyome Holdings, Inc. (HIND)
NASDAQ: HIND · Real-Time Price · USD
5.17
-0.24 (-4.44%)
At close: Sep 26, 2025, 4:00 PM EDT
5.10
-0.07 (-1.35%)
After-hours: Sep 26, 2025, 7:23 PM EDT
Vyome Holdings Revenue
Vyome Holdings had revenue of $49.95K in the quarter ending June 30, 2025, with 46.88% growth. This brings the company's revenue in the last twelve months to $394.49K, up 30.16% year-over-year. In the year 2024, Vyome Holdings had annual revenue of $256.94K, down -38.23%.
Revenue (ttm)
$394.49K
Revenue Growth
+30.16%
P/S Ratio
72.94
Revenue / Employee
$21,916
Employees
18
Market Cap
28.77M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 256.94K | -159.00K | -38.23% |
Dec 31, 2023 | 415.94K | 33.08K | 8.64% |
Dec 31, 2022 | 382.87K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionHIND News
- 10 days ago - Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity - Business Wire
- 18 days ago - Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies - Business Wire
- 23 days ago - Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity - Business Wire
- 5 weeks ago - Vyome Signs MoU with Embryyo, India's Leading Medical Device Innovation Studio - Business Wire
- 5 weeks ago - Vyome Announces Strategic Review of Livechain (OTCID: LICH) - Business Wire
- 6 weeks ago - Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell - Business Wire
- 6 weeks ago - Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow - Business Wire
- 6 weeks ago - Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND - Business Wire